Literature DB >> 33127555

Chemical constituents of Panax ginseng and Panax notoginseng explain why they differ in therapeutic efficacy.

Hanbing Liu1, Xiaoyan Lu2, Yang Hu2, Xiaohui Fan3.   

Abstract

Panax ginseng (Meyer) and Panax notoginseng (Burkill), belonging to the family Araliaceae, are used worldwide as medicinal and functional herbs. Numerous publications over the past decades have revealed that both P. notoginseng and P. ginseng contain important bioactive ingredients such as ginsenosides and exert multiple pharmacological effects on nervous system and immune diseases. However, based on traditional Chinese medicine (TCM) theory, their applications clearly differ as ginseng reinforces vital energy and notoginseng promotes blood circulation. In this article, we review the similarities and differences between ginseng and notoginseng in terms of their chemical composition and pharmacological effects. Their chemical comparisons indicate that ginseng contains more polysaccharides and amino acids, while notoginseng has more saponins, volatile oil, and polyacetylenes. Regarding pharmacological effects, ginseng exhibits better protective effects on cardiovascular disease, nerve disease, cancer, and diabetes mellitus, whereas notoginseng displays a superior protective effect on cerebrovascular disease. The evidence presented in this review facilitates further research and clinical applications of these two herbs, and exploration of the relationship between the chemical components and disease efficacy may be the critical next step.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Arginine (PubChem CID: 6322); Aspartic acid (PubChem CID: 5960); Cardiovascular disease; Cerebral protection; Dencichine (PubChem CID: 440259); Falcarinol (PubChem CID: 5281149); Ginsenoside Rb(1) (PubChem CID: 9898279); Ginsenoside Rd (PubChem CID: 24721561); Ginsenoside Re (PubChem CID: 119307); Ginsenoside Rg(1) (PubChem CID: 441923); N-Hexadecanoic acid (PubChem CID: 985); Notoginsenoside R(1) (PubChem CID: 441934); Panax ginseng; Panax notoginseng

Year:  2020        PMID: 33127555     DOI: 10.1016/j.phrs.2020.105263

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  14 in total

1.  Systematic Qualitative and Quantitative Analyses of Wenxin Granule via Ultra-High Performance Liquid Chromatography Coupled with Ion Mobility Quadrupole Time-of-Flight Mass Spectrometry and Triple Quadrupole-Linear Ion Trap Mass Spectrometry.

Authors:  Yueguang Mi; Wandi Hu; Weiwei Li; Shiyu Wan; Xiaoyan Xu; Meiyu Liu; Hongda Wang; Quanxi Mei; Qinhua Chen; Yang Yang; Boxue Chen; Meiting Jiang; Xue Li; Wenzhi Yang; Dean Guo
Journal:  Molecules       Date:  2022-06-06       Impact factor: 4.927

Review 2.  Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation.

Authors:  Zhaoqiang Chen; Zepeng Zhang; Jiaqi Liu; Hongyu Qi; Jing Li; Jinjin Chen; Qingxia Huang; Qing Liu; Jia Mi; Xiangyan Li
Journal:  Front Cell Infect Microbiol       Date:  2022-04-25       Impact factor: 6.073

3.  Tengdan Capsule Prevents Hypertensive Kidney Damage in SHR by Inhibiting Periostin-Mediated Renal Fibrosis.

Authors:  Xiaoli Du; Qianqian Tao; Hongxia Du; Zhenbang Zhao; Yu Dong; Shuang He; Rui Shao; Yule Wang; Wenrun Han; Xintong Wang; Yan Zhu
Journal:  Front Pharmacol       Date:  2021-05-18       Impact factor: 5.810

Review 4.  Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies.

Authors:  Hong Wang; Yu Zheng; Qiang Sun; Zhen Zhang; Mengnan Zhao; Cheng Peng; Sanjun Shi
Journal:  J Nanobiotechnology       Date:  2021-10-15       Impact factor: 10.435

5.  Anti-Inflammatory Effects of Ginsenoside Rb3 in LPS-Induced Macrophages Through Direct Inhibition of TLR4 Signaling Pathway.

Authors:  Honglin Xu; Min Liu; Guanghong Chen; Yuting Wu; Lingpeng Xie; Xin Han; Guoyong Zhang; Zhangbin Tan; Wenjun Ding; Huijie Fan; Hongmei Chen; Bin Liu; Yingchun Zhou
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

6.  Rapid Identification of Characteristic Chemical Constituents of Panax ginseng, Panax quinquefolius, and Panax japonicus Using UPLC-Q-TOF/MS.

Authors:  Liu Jinbiao; Zhang Xinyue; Yang Shenshen; Wang Shuo; Liu Chengcheng; Yang Bin; Li Yubo; Cai Ting
Journal:  J Anal Methods Chem       Date:  2022-02-15       Impact factor: 2.193

7.  A Novel Biochemical Study of Anti-Dermal Fibroblast Replicative Senescence Potential of Panax Notoginseng Oligosaccharides.

Authors:  Lu Zhai; Xiaohao Xu; Jiangzeng Liu; Chenxu Jing; Xinzhao Yang; Daqing Zhao; Rui Jiang; Li-Wei Sun
Journal:  Front Pharmacol       Date:  2021-06-30       Impact factor: 5.810

8.  Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Eunhak Seong; Shambhunath Bose; Song-Yi Han; Eun-Ji Song; Myeongjong Lee; Young-Do Nam; Hojun Kim
Journal:  EPMA J       Date:  2021-06-03       Impact factor: 8.836

9.  Antioxidant Effect and Sensory Evaluation of Yogurt Supplemented with Hydroponic Ginseng Root Extract.

Authors:  Hyun Sook Lee; Myung Wook Song; Kee-Tae Kim; Wan-Soo Hong; Hyun-Dong Paik
Journal:  Foods       Date:  2021-03-17

10.  Protective effects of notoginsenoside R1 on acute lung injury in rats with sepsis.

Authors:  Bo Cao; Zhaoxia Xu; Chang Liu; Jian Hu; Zhongli Zhu; Junya Li; Guoyun Zhu; Fuxiang Li
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.